TILT, NCT00105235: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients |
|
|
| Completed | 2 | 27 | US, Canada | Alemtuzumab, Campath, Cyclosporine, Mycophenolate mofetil, CellCept, Tacrolimus, FK-506, Fujimycin, Liver transplant, Immunosuppression withdrawal | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN) | Liver Disease, Liver Transplantation | 03/07 | 03/11 | | |
CHASE, NCT00295607 / 2004-004561-14: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients |
|
|
| Completed | 2 | 138 | Europe | Tacrolimus, Prograf, FK506, steroids, monoclonal anti-IL2R antibody | Astellas Pharma Inc | Hepatitis C, Liver Transplantation | 06/08 | 06/08 | | |
NCT00772148: Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients |
|
|
| Completed | 2 | 58 | US | LCP -Tacro, tacrolimus, Prograf | Veloxis Pharmaceuticals, CTI Clinical Trial and Consulting Services, Aptuit Inc. | Liver Failure | 05/10 | 05/10 | | |
